Sample | Title | Value | Rank |
GSM1256964 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 1 | 54.6672 | 72 |
GSM1256965 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 2 | 81.6125 | 76 |
GSM1256966 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 3 | 83.1492 | 77 |
GSM1256967 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 4 | 66.8294 | 73 |
GSM1256980 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 54 before YFV | 31.0535 | 61 |
GSM1256984 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 54 seven days after YFV | 50.5254 | 70 |
GSM1256981 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 55 before YFV | 58.4168 | 71 |
GSM1256985 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 55 seven days after YFV | 55.74 | 69 |
GSM1256982 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 56 before YFV | 30.44 | 61 |
GSM1256986 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 56 seven days after YFV | 46.001 | 68 |
GSM1256983 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 57 before YFV | 63.3206 | 73 |
GSM1256987 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 57 seven days after YFV | 49.4135 | 70 |